{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:48:02Z","timestamp":1794376082293,"version":"4.9.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2017 SGR 103"],"award-info":[{"award-number":["2017 SGR 103"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.nano.2022.102635","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:47:56Z","timestamp":1670273276000},"page":"102635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens"],"prefix":"10.1016","volume":"48","author":[{"given":"Lidia","family":"Almenara-Fuentes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rodriguez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Rosell-Mases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Kachler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Salvado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darja","family":"Andreev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Bozec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozen","family":"Le Panse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Verdaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marti","family":"Dalmases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rodriguez-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Barneda-Zahonero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3735-0779","authenticated-orcid":false,"given":"Marta","family":"Vives-Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2022.102635_bb0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.nano.2022.102635_bb0010","first-page":"11","article-title":"The emerging jamboree of transformative therapies for autoimmune diseases","author":"Carballido","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2249.2009.04082.x","article-title":"Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes","volume":"160","author":"Marin-Gallen","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127057","article-title":"Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes","volume":"10","author":"Pujol-Autonell","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.nano.2022.102635_bb0030","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.2217\/nnm-2016-0410","article-title":"Liposome-based immunotherapy against autoimmune diseases: therapeutic effect on multiple sclerosis","volume":"12","author":"Pujol-Autonell","year":"2017","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2022.102635_bb0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fimmu.2018.00253","article-title":"Phosphatidylserine-liposomes promote tolerogenic features on dendritic cells in human type 1 diabetes by apoptotic mimicry","volume":"9","author":"Rodriguez-Fernandez","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0040","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.3389\/fimmu.2019.02811","article-title":"Impaired phagocytosis in dendritic cells from pediatric patients with type 1 diabetes does not hamper their tolerogenic potential","volume":"10","author":"Rodriguez-Fernandez","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0045","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ni.3253","article-title":"Phagocytosis of apoptotic cells in homeostasis","volume":"16","author":"Arandjelovic","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0050","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/jbmr.3158","article-title":"Periarticular bone loss in arthritis is induced by autoantibodies against citrullinated vimentin","volume":"32","author":"Engdahl","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.nano.2022.102635_bb0055","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2022.102635_bb0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0092-8674(00)81109-5","article-title":"Rheumatoid arthritis","volume":"85","author":"Feldmann","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nano.2022.102635_bb0065","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/art.1780200314","article-title":"Antigen-induced arthritis in mice","volume":"20","author":"Brackertz","year":"1977","journal-title":"ArthritisRheum"},{"key":"10.1016\/j.nano.2022.102635_bb0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.nano.2022.102635_bb0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1084\/jem.191.3.411","article-title":"The induction of tolerance by dendritic cells that have captured apoptotic cells","volume":"191","author":"Steinman","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.nano.2022.102635_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10495-015-1090-8","article-title":"How apoptotic \u03b2-cells direct immune response to tolerance or to autoimmune diabetes: a review","volume":"20","author":"Vives-Pi","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.nano.2022.102635_bb0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2353\/ajpath.2007.070135","article-title":"Immunological consequences of apoptotic cell phagocytosis","volume":"171","author":"Erwig","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nano.2022.102635_bb0090","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nri2214","article-title":"Engulfment of apoptotic cells: signals for a good meal","volume":"7","author":"Ravichandran","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063296","article-title":"Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity","volume":"8","author":"Pujol-Autonell","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.nano.2022.102635_bb0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/cr.2010.19","article-title":"Endocytosis unplugged: multiple ways to enter the cell","volume":"20","author":"Kumari","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.nano.2022.102635_bb0105","first-page":"10","article-title":"Systemic review of biodegradable nanomaterials in nanomedicine","author":"Su","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.nano.2022.102635_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1900\/RDS.2005.2.121","article-title":"B cells in autoimmune diabetes","volume":"2","author":"Wong","year":"2005","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.nano.2022.102635_bb0115","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.3389\/fimmu.2021.746187","article-title":"Regulatory B cells: role in type 1 diabetes","volume":"12","author":"Boldison","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0120","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1111\/all.14763","article-title":"Regulatory B cells,A to Z","volume":"76","author":"Jansen","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.nano.2022.102635_bb0125","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1172\/JCI46274","article-title":"Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice","volume":"121","author":"Ding","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1016\/j.nano.2022.102635_bb0130","doi-asserted-by":"crossref","first-page":"14080","DOI":"10.1073\/pnas.0700326104","article-title":"Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells","volume":"104","author":"Gray","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nano.2022.102635_bb0135","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.4049\/jimmunol.181.3.1806","article-title":"CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis","volume":"181","author":"Tang","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0140","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.nano.2022.102635_bb0145","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.3389\/fimmu.2021.684240","article-title":"Re-programming autoreactive T cells into T-regulatory type 1 cells for the treatment of autoimmunity","volume":"12","author":"Sol\u00e9","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0150","first-page":"471","article-title":"Changes in peripheral CD19(+)Foxp3(+) and CD19(+)TGF\u03b2(+) regulatory B cell populations in rheumatoid arthritis patients with interstitial lung disease","volume":"7","author":"Guo","year":"2015","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.nano.2022.102635_bb0155","first-page":"1","article-title":"Amelioration of autoimmune arthritis by adoptive transfer of Foxp3-expressing regulatory B cells is associated with the Treg\/Th17 cell balance","volume":"14","author":"Park","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.nano.2022.102635_bb0160","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.3389\/fimmu.2019.02566","article-title":"Soluble CD137 ameliorates acute type 1 diabetes by inducing T cell anergy","volume":"10","author":"Itoh","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0165","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1172\/JCI126595","article-title":"Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression","volume":"130","author":"Wiedeman","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2022.102635_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cellimm.2017.07.007","article-title":"Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes","volume":"319","author":"Long","year":"2017","journal-title":"Cell Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0175","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.4049\/jimmunol.166.10.6430","article-title":"Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis","volume":"166","author":"Wang","year":"2001","journal-title":"JImmunol"},{"key":"10.1016\/j.nano.2022.102635_bb0180","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.4049\/jimmunol.1003021","article-title":"Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells","volume":"186","author":"Notley","year":"2011","journal-title":"JImmunol"},{"key":"10.1016\/j.nano.2022.102635_bb0185","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12967-019-2128-4","article-title":"Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis","volume":"17","author":"Spiering","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/j.nano.2022.102635_bb0190","first-page":"3987","article-title":"B cells in rheumatoid arthritis: pathogenic mechanisms and treatment prospects","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0195","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3389\/fimmu.2020.00776","article-title":"Autoimmune pathology in myasthenia gravis disease subtypes is governed by divergent mechanisms of immunopathology","volume":"11","author":"Fichtner","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2022.102635_bb0200","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/imcb.12439","article-title":"A century later, still fighting back: antigen-specific immunotherapies for type 1 diabetes","volume":"99","author":"Rodriguez-Fernandez","year":"2021","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.nano.2022.102635_bb0205","first-page":"77","article-title":"Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes","volume":"48","author":"Villalba","year":"2020","journal-title":"ArtifCellsNanomedBiotechnol"},{"key":"10.1016\/j.nano.2022.102635_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12645-019-0055-y","article-title":"Nanomedicine review: clinical developments in liposomal applications","volume":"10","author":"Beltr\u00e1n-Gracia","year":"2019","journal-title":"Cancer Nanotechnol"},{"key":"10.1016\/j.nano.2022.102635_bb0215","first-page":"14","article-title":"Brief on recent application of liposomal vaccines for lower respiratory tract viral infections: from influenza to COVID-19 vaccines","author":"Attia","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.nano.2022.102635_bb0220","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1002\/jbm.a.36151","article-title":"Control of autoimmune inflammation using liposomes to deliver positive allosteric modulators of metabotropic glutamate receptors","volume":"105","author":"Gammon","year":"2017","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.nano.2022.102635_bb0225","first-page":"13","article-title":"Retinoic acid-containing liposomes for the induction of antigen-specific regulatory T cells as a treatment for autoimmune diseases","author":"ter Braake","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2022.102635_bb0230","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jconrel.2018.08.007","article-title":"Peptide-directed liposomal delivery improves the therapeutic index of an immunomodulatory cytokine in controlling autoimmune arthritis","volume":"286","author":"Meka","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2022.102635_bb0235","first-page":"4","article-title":"PD-L1\u2013 and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease","author":"Galea","year":"2019","journal-title":"JCIInsight"},{"key":"10.1016\/j.nano.2022.102635_bb0240","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.4049\/jimmunol.1901128","article-title":"Regulatory T cells induced by single-peptide liposome immunotherapy suppress islet-specific T cell responses to multiple antigens and protect from autoimmune diabetes","volume":"204","author":"Bergot","year":"2020","journal-title":"JImmunol"},{"key":"10.1016\/j.nano.2022.102635_bb0245","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/bbb\/zbaa084","article-title":"The evaluation of lymph node cell proliferation response by liposomes loaded with major histocompatibility complex class II binding aquaporin 4 antigen peptide","volume":"85","author":"Muraki","year":"2021","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.nano.2022.102635_bb0250","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1073\/pnas.1015623108","article-title":"Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair","volume":"108","author":"Harel-Adar","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2022.102635_bb0255","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2174\/1381612823666170214120708","article-title":"Cell-based tolerogenic therapy, experience from animal models of multiple sclerosis, type 1 diabetes and rheumatoid arthritis","volume":"23","author":"Stojanovic","year":"2017","journal-title":"Curr Pharm Des"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963422001216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963422001216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:18:19Z","timestamp":1761549499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963422001216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":51,"alternative-id":["S1549963422001216"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2022.102635","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2022.102635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102635"}}